Abstract

ObjectiveIn the present study, cerebrospinal fluid (CSF) profiles were assessed to determine how idiopathic normal pressure hydrocephalus (NPH) and Alzheimer’s disease (AD) differs.MethodsSubjects were drawn from patients who underwent lumbar punctures as part of their diagnostic evaluations in the Banner Sun Health Research Institute Memory Disorders clinic. The clinical sample included 11 iNPH subjects (mean age 81.36±2.58) and 11 AD subjects (mean age 61.46±8.24). Concentrations of amyloid-β (Aβ42), total-tau (t-tau), phospho-tau181 (p-tau) Aβ42, and an Aβ42-Tau Index (ATI) were measured by commercial assay (Athena Diagnostics). and compared to each other. The Mann-Whitney test was used to assess group differences on the raw values for Aβ42, t-tau, p-tau, ATI, age, education, and MMSE.ResultsIn a univariate analysis, p-tau was found to be significantly (P = 0.009) lower in patients diagnosed with iNPH than those with AD. Amyloid-β (Aβ42), total-tau (t-tau) did not differ between groups. In multi-variate analysis, the differences in p-tau between groups did not differ.ConclusionAlthough age could represent a significant confound, p-tau is significantly lower in iNPH compared to AD. P-tau would be expected to increase with age but in this sample is lower suggesting the difference might be explained by the underlying condition.

Highlights

  • Alzheimer’s disease (AD) is characterized by a progressive dementia, the presence of neuritic plaques, and nerve cell degeneration [1]

  • Conclusion— age could represent a significant confound, p-tau is significantly lower in Idiopathic normal pressure hydrocephalus (iNPH) compared to AD

  • The 22 cases used for this sample were divided evenly between the AD and iNPH groups

Read more

Summary

Introduction

Alzheimer’s disease (AD) is characterized by a progressive dementia, the presence of neuritic plaques, and nerve cell degeneration [1]. The sensitivity and specificity for Aβ42 to discriminate AD from non-demented individuals is 86% and 89%, respectively; for t-tau, 81% and 91%, respectively; regarding p-tau, 81% and 91%, respectively; and for the combination of t-tau and Aβ42, 89% and 90% respectively [8]. These same biomarkers are much less understood when applied to iNPH, as results from studies are contradictory [9, 10]. More studies are required to assess current biomarkers and discover new indicators of dementia, for AD and iNPH

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call